153182-57-1 Usage
Description
(4R,5S,6S,7R)-4,7-dibenzyl-1,3-bis(4-bromobenzyl)-5,6-dihydroxy-1,3-diazepan-2-one is a complex organic molecule characterized by a diazepan-2-one ring structure. It features four benzyl groups, two bromobenzyl groups, and two hydroxyl groups attached to the diazepan ring. As a chiral molecule, it exhibits specific stereochemistry, denoted by the (4R,5S,6S,7R) configuration. This unique structure and the presence of various functional groups suggest potential applications in medicinal chemistry, particularly in the development of new drugs and pharmaceuticals. Further research and analysis are required to fully comprehend the properties and potential uses of this compound.
Uses
Used in Pharmaceutical Development:
(4R,5S,6S,7R)-4,7-dibenzyl-1,3-bis(4-bromobenzyl)-5,6-dihydroxy-1,3-diazepan-2-one is used as a key intermediate in the synthesis of novel pharmaceuticals for [application reason]. Its unique structure and functional groups make it a promising candidate for the development of new drugs with specific therapeutic targets.
Used in Medicinal Chemistry Research:
In the field of medicinal chemistry, (4R,5S,6S,7R)-4,7-dibenzyl-1,3-bis(4-bromobenzyl)-5,6-dihydroxy-1,3-diazepan-2-one is used as a structural template for designing new molecules with potential therapeutic applications. (4R,5S,6S,7R)-4,7-dibenzyl-1,3-bis(4-bromobenzyl)-5,6-dihydroxy-1,3-diazepan-2-one's chirality and functional groups allow for the exploration of various chemical modifications to optimize its pharmacological properties.
Used in Drug Delivery Systems:
(4R,5S,6S,7R)-4,7-dibenzyl-1,3-bis(4-bromobenzyl)-5,6-dihydroxy-1,3-diazepan-2-one can be utilized in the development of innovative drug delivery systems, such as nanoparticles or liposomes, to improve the bioavailability and targeting of therapeutic agents. (4R,5S,6S,7R)-4,7-dibenzyl-1,3-bis(4-bromobenzyl)-5,6-dihydroxy-1,3-diazepan-2-one's structural features may facilitate the design of carriers with enhanced stability and controlled release properties.
Used in Chemical Synthesis:
As a complex organic molecule, (4R,5S,6S,7R)-4,7-dibenzyl-1,3-bis(4-bromobenzyl)-5,6-dihydroxy-1,3-diazepan-2-one can be employed as a starting material or building block in the synthesis of other complex organic compounds. Its unique structure and functional groups may enable the creation of novel molecules with diverse applications in various industries, including materials science, agrochemistry, and environmental science.
Check Digit Verification of cas no
The CAS Registry Mumber 153182-57-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,5,3,1,8 and 2 respectively; the second part has 2 digits, 5 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 153182-57:
(8*1)+(7*5)+(6*3)+(5*1)+(4*8)+(3*2)+(2*5)+(1*7)=121
121 % 10 = 1
So 153182-57-1 is a valid CAS Registry Number.
153182-57-1Relevant articles and documents
Cyclic HIV protease inhibitors: Synthesis, conformational analysis, P2/P2' structure-activity relationship, and molecular recognition of cyclic ureas
Lam, Patrick Y. S.,Ru, Yu,Jadhav, Prabhakar K.,Aldrich, Paul E.,DeLucca, George V.,Eyermann, Charles J.,Chang, Chong-Hwan,Emmett, George,Holler, Edward R.,Daneker, Wayne F.,Li, Liangzhu,Confalone, Pat N.,McHugh, Robert J.,Han, Qi,Li, Renhua,Markwalder, Jay A.,Seitz, Steven P.,Sharpe, Thomas R.,Bacheler, Lee T.,Rayner, Marlene M.,Klabe, Ronald M.,Shum, Linyee,Winslow, Dean L.,Kornhauser, David M.,Jackson, David A.,Erickson-Viitanen, Susan,Hodge, C. Nicholas
, p. 3514 - 3525 (2007/10/03)
High-resolution X-ray structures of the complexes of HIV-1 protease (HIV-1PR) with peptidomimetic inhibitors reveal the presence of a structural water molecule which is hydrogen bonded to both the mobile flaps of the enzyme and the two carbonyls flanking
